Enantia enters into the capital of Janus Developments

Effective December 23rd, 2009, Enantia entered into the capital of Janus Developments along with two additional investors: the pharmaceutical group Ferrer Internacional and the financial institution Caixa Manresa. Following Enantia's strategy to be closer to the emerging biotech sector, we decided to tighten relations with the recently founded start-up Janus Developments by entering into its capital. More detailed information can be found in the article appeared in Diario Expansión on January 20th, 2010.

(Jan 20th, 2010)

 


Latest news

Enantia has been awarded the "Premio Senén Vilaró 2011"

 

Enantia has been awarded the "Premio Senén Vilaró 2011" as the best innovatory company that has spun off from an academic group from the University of Barcelona.

Commercial Model

With a flexible commercial model, we execute projects through FTE service agreements but also through a variety of different approaches like: fee per success, fee per project or through a shared risk approach.